Pharmaceutical Industry Blog

Last Updated: August 17, 2026 TL;DR: Senegal's pharmaceutical market is regulated by the Agence sénégalaise de Réglementation Pharmaceutique (ARP), created in 2022 (Decree No. 2022-824) and formalized under Law No. 2023-06, which absorbed the former Direction de la Pharmacie et du Médicament (DPM). In December 2024, ARP became the first Francophone African regulator to reach WHO Maturity Level 3, though Senegal, like the rest of West Africa, is not a PIC/S member. As a WAEMU/

Last Updated: August 17, 2026 TL;DR: Somalia's pharmaceutical oversight is administered by the National Medicines Regulatory Authority (NMRA), operating under the Federal Ministry of Health & Human Services as an Interim NMRA since 2023, built on the 1989 pharmacy law and the 2014 National Medicines Policy, with a roadmap benchmarked against WHO's Global Benchmarking Tool. Somalia has not yet achieved a formal WHO maturity rating and sits outside PIC/S, so import approval in

Last Updated: July 29, 2026 TL;DR: Chile registers medicines through the Instituto de Salud Pública (ISP) under Decreto Supremo N°3 of 2010, using a five-module CTD dossier formally adopted in 2020, with a standard legal-evaluation timeline of roughly five to six months that can shorten to about three months for products already approved by a recognised high-surveillance authority. Chile is not currently a member, applicant or pre-applicant of the PIC/S GMP cooperation scheme

Last Updated: July 29, 2026 TL;DR: Kazakhstan registers medicines through the Eurasian Economic Union's unified procedure, mandatory for new dossiers since January 2021, using an EAEU Common Technical Document format reviewed by a reference-state authority together with one or more recognition states, typically inside a ceiling of roughly 300 calendar days. In April 2026 the World Health Organization designated Kazakhstan a Maturity Level 3 regulatory authority, the first in

Last Updated: July 28, 2026 TL;DR: Chad imports more than 90% of the medicines it consumes and has no meaningful domestic sterile injectable manufacturing capacity. Registration is administered by the Direction Generale de la Pharmacie, du Medicament et des Laboratoires (DGPML) under the Ministry of Public Health, applying Loi n024/PR/2000 relative a la Pharmacie. As a CEMAC member state alongside Cameroon, Central African Republic, Congo, Gabon and Equatorial Guinea, Chad ha

Last Updated: July 28, 2026 TL;DR: Zambia imports an estimated 80-90% of the medicines it consumes, and India already supplies more than 46% of those pharmaceutical imports by value - yet sterile injectable manufacturing capacity inside the country remains minimal. The regulator is the Zambia Medicines Regulatory Authority (ZAMRA), established under the Medicines and Allied Substances Act No. 3 of 2013, which reviews marketing-authorisation dossiers in CTD format and aligns i